Active	Status	Sponsor type	Region	Phase	Filter
4 Active 9 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ruschitzka, Frank
DAPA-VOLVO, NCT04869124: Dapagliflozin on Volume Vascular Outcomes.	Recruiting	4	80	Europe	Dapagliflozin, Forxiga, Placebo	Frank Ruschitzka, AstraZeneca	Heart Failure，Congestive	12/24	12/24
OPIOVASC, NCT03781544: Effects of Opioids and NSAIDs on Sympathetic Nervous System and Vascular Function	Recruiting	4	90	Europe	Tramadol, Tramadol-Mepha, Paracetamol, PARACETAMOL Sintetica, Diclofenac	University of Zurich	Osteoarthritis of Multiple Joints of Ankle or Foot, Healthy	07/25	12/25
Flammer, Andreas J
RVA-CRT, NCT04379401: Acute Impact of Cardiac Resynchronization on Vascular Function	Completed	N/A	35	Europe	Cardiac Resynchronization Therapy (ON vs. OFF)	Andreas Flammer	Heart Failure	06/23	06/23
Sokolski, Mateusz
LSCSI, NCT05465200: Lower Silesia Cardiogenic Shock Initiative	Recruiting	N/A	50	Europe	Structured treatment of cardiogenic shock patients	Wroclaw Medical University	Cardiogenic Shock	01/27	01/28